9 Best Rising Penny Stocks to Buy According to Wall Street Analysts
In this article, we will look at the 9 Best Rising Penny Stocks to Buy According to Wall Street Analysts.
Lexicon Pharmaceuticals Inc. (LXRX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Siren L.L.C. Raymond Debbane | 44,303,518 | $106,328,443 | 2.15% | |
| 2. | Sessa Capital John Petry | 18,960,836 | $45,506,006 | +6% | 0.76% |
| 3. | Point72 Asset Management Steve Cohen | 8,251,325 | $19,803,180 | +6% | 0.02% |
| 4. | Citadel Investment Group Ken Griffin | 1,601,182 | $3,842,837 | +47% | 0% |
| 5. | Millennium Management Israel Englander | 1,134,229 | $2,722,150 | -78% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.49 | 2,000 | $2,980.00 | 1,906,186 | 2026-02-25 | Filing | |
| $1.47 | 100,000 | $147,000.00 | 1,904,186 | 2026-02-23 | Filing | |
| $1.48 | 100,000 | $147,790.00 | 1,804,186 | 2026-02-20 | Filing | |
| $1.44 | 50,000 | $71,965.00 | 1,704,186 | 2026-02-19 | Filing | |
| $1.32 | 133,688 | $176,468.16 | 1,654,186 | 2026-02-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.93 | 12,000 | $83,100.00 | 71,766 | 2021-03-15 | Filing | |
| $6.90 | 10,912 | $75,339.72 | 71,766 | 2021-03-15 | Filing | |
| $12.91 | 10,000 | $129,076.00 | 25,643 | 2018-06-08 | Filing | |
| $15.00 | 1,500 | $22,500.00 | 15,946 | 2016-06-06 | Filing | |
| $13.00 | 6,000 | $78,000.00 | 15,946 | 2016-05-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 175,156,062 | $420,374,549 | 45.15% | |
| 2. | 51,782,045 | $124,276,907 | 0.01% | |
| 3. | 17,348,741 | $41,636,978 | 0% | |
| 4. | 9,901,208 | $23,762,899 | 0% | |
| 5. | 6,244,372 | $14,989,739 | 0% |
News See All
Is Lexicon Pharmaceuticals, Inc. (LXRX) A Good Stock To Buy Now?
Is LXRX a good stock to buy? We came across a bullish thesis on Lexicon Pharmaceuticals, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on LXRX.
10 Best Penny Stocks to Buy for Long Term
In this article, we will look at the 10 Best Penny Stocks to Buy for Long Term.
8 Best Fast Growing Penny Stocks to Buy Right Now
In this article, we will discuss the 8 Best Fast Growing Penny Stocks to Buy Right Now.
9 Best Biotech Penny Stocks to Buy in 2026
In this article, we will discuss the 9 Best Biotech Penny Stocks to Buy in 2026.
10 Best Penny Stocks to Buy and Hold Under $5
In this article, we will look at the 10 Best Penny Stocks to Buy and Hold Under $5. Smaller companies have started to attract more attention on Wall Street.
10 High-Flying Penny Stocks to Buy
In this article, we will look at the 10 High-Flying Penny Stocks to Buy.
H.C. Wainwright Raises its Price Target on Lexicon Pharmaceuticals, Inc. (LXRX) to $6 from $4 and Maintains a Buy Rating
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is among the 11 Fastest Growing Penny Stocks to Buy Right Now. On March 5, 2026, H.C. Wainwright raised the price target on Lexicon Pharmaceuticals, Inc.
11 Fastest Growing Penny Stocks to Buy Right Now
In this article, we will look at the 11 Fastest Growing Penny Stocks to Buy Right Now. Interest in smaller companies has been quietly building on Wall Street.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2025 Earnings Call Transcript
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2025 Earnings Call Transcript March 5, 2026Lexicon Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.04, expectations were $-0.07.
Hedge Fund Resource Center